
Opinion|Videos|June 17, 2024
Quality of Life and Progression Considerations in BCG-Unresponsive NMIBC
Bladder cancer experts discuss quality of life and progression considerations and their impact on treatment decisions for patients with BCG-unresponsive NMIBC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
Microbial dysbiosis may predict response to CBM588 in mRCC
5












